TNXP
Tonix Pharmaceuticals Holding Corp.
NASDAQ · Healthcare · Biotechnology · US
$5.16
−2.31%Margins
Gross margin
80.2%
EBITDA margin
-541.3%
EBIT margin
-568.4%
Net margin
-548.6%
FCF margin
-549.4%
-71.8%
Return on equity
-62.8%
Return on assets
-74.0%
Return on invested capital
0.11x
Asset turnover
-$154.7M
Cash from operations
$10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026